2023-01-20 PUT at $5.0 Option on Immunoprecise Antibodies

IPA
 Stock
  

USD 5.30  0.21  3.81%   

2023-01-20 PUT at $5.0 is a PUT option contract on Immunoprecise Antibodies' common stock with a strick price of 5.0 expiring on 2023-01-20. The contract was last traded on 2022-05-11 at 15:14:12 for $1.89 and, as of today, has 157 days remaining before the expiration. The option is currently trading at a bid price of $0.7, and an ask price of $4.1. The implied volatility as of the 16th of August 2022 is 205.7502.
  
Please see Risk vs Return Analysis.
A put option written on Immunoprecise Antibodies becomes more valuable as the price of Immunoprecise Antibodies drops. Conversely, Immunoprecise Antibodies' put option loses its value as Immunoprecise Stock rises. When exercised, put options on Immunoprecise Antibodies produce a short position in Immunoprecise Stock. Because of this protective nature, they are typically used either for hedging purposes or to capitalize on Immunoprecise Antibodies' downside price movement.

Rule 16 of 2023-01-20 Option Contract

The options market is anticipating that Immunoprecise Antibodies will have an average daily up or down price movement of about 12.86% per day over the life of the option. With Immunoprecise Antibodies trading at $5.3, that is roughly $0.68. If you think that the market is fully understating Immunoprecise Antibodies' daily price movement you should consider buying Immunoprecise Antibodies options at that current volatility level of 205.75%. But if you have an opposite viewpoint you should avoid it and even consider selling them.

Out Of The Money Put Option on Immunoprecise Antibodies

An 'Out of The Money' option on Immunoprecise has a strike price that Immunoprecise Stock has yet to reach, meaning the option has no intrinsic value. 'Out of The Money' options are usually less costly than 'In The Money' options, making them more desirable to traders with smaller amounts of capital. Some of the uses for Immunoprecise Antibodies' 'Out of The Money' options include buying the options if you expect a big move in Immunoprecise Antibodies' stock. Since 'Out of The Money' options have a lower up-front cost (i.e., no intrinsic value) than 'In The Money' options, buying it is a reasonable choice.
Put Contract Name2023-01-20 PUT at $5.0
Expires On2023-01-20
Days Before Expriration157
Last Traded On2022-05-11 15:14:12
Contract PeriodMONTHLY
Open Interest22
Current Trading Volume5.0
Strike Price5.0
Last Traded At1.89
Current Price Spread0.7 | 4.1
Rule 16 Daily Up or Down$0.68

Immunoprecise short PUT Option Greeks

Immunoprecise Antibodies' Option Greeks for the contract ending on 2023-01-20 at a strike price of 5.0 measures the various factors that affect its cost and calculated using a theoretical options pricing model. It helps investors make more informed decisions about whether to trade this option contract or when to trade it. In addition to Immunoprecise Antibodies' option greeks, its implied volatility helps estimate the risk of Immunoprecise Antibodies stock implied by the prices of the options on Immunoprecise Antibodies' stock.
Delta-0.2343
Gamma0.0429
Theta-0.0067
Vega0.0107
Rho-0.0128

Immunoprecise long PUT Option Payoff at expiration

Put options written on Immunoprecise Antibodies grant holders of the option the right to sell a specified amount of Immunoprecise Antibodies at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Immunoprecise Stock cannot fall below zero, the put buyer does gain as the price drops. So, purchasing a put option on Immunoprecise Antibodies is like buying insurance aginst Immunoprecise Antibodies' downside shift.
   Profit   
Share
       Immunoprecise Antibodies Price At Expiration  

Immunoprecise short PUT Option Payoff at expiration

By selling Immunoprecise Antibodies' put option, the investors signal their bearish sentiment. A short position in a put option written on Immunoprecise Antibodies will generally make money when the underlying price is above the strike price. Therefore Immunoprecise Antibodies' put payoff at expiration depends on where the Immunoprecise Stock price is relative to the put option strike price. The breakeven price of 2.6 is the critical point that divides the payoff function into two parts. Below the breakeven price, the payoff is dropping and negative (the seller makes a loss). Above the breakeven price, the payoff line is upward sloping as the option payoff increases in proportion to Immunoprecise Antibodies' price. Finally, at the strike price of 5.0, the payoff chart is constant and positive.
   Profit   
Share
       Immunoprecise Antibodies Price At Expiration  
View All Immunoprecise Antibodies Options

Immunoprecise Antibodies Available Put Options

Immunoprecise Antibodies' option chain is a display of a range of information that helps investors for ways to trade options on Immunoprecise. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Immunoprecise. It also shows strike prices and maturity days for a Immunoprecise Antibodies against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
DeltaGammaOpen IntExpirationCurrent SpreadLast Price
 Put
2022-08-19 PUT at $7.5-0.48720.0869372022-08-191.8 - 5.03.48In
 Put
2022-08-19 PUT at $10.0-0.58290.078612022-08-194.3 - 7.04.8In

Immunoprecise Antibodies Investors Sentiment

The influence of Immunoprecise Antibodies' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Immunoprecise. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Immunoprecise Antibodies Implied Volatility

    
  143.03  
Immunoprecise Antibodies' implied volatility exposes the market's sentiment of Immunoprecise Antibodies stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Immunoprecise Antibodies' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Immunoprecise Antibodies stock will not fluctuate a lot when Immunoprecise Antibodies' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Immunoprecise Antibodies in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Immunoprecise Antibodies' short interest history, or implied volatility extrapolated from Immunoprecise Antibodies options trading.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Immunoprecise Antibodies using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Risk vs Return Analysis. Note that the Immunoprecise Antibodies information on this page should be used as a complementary analysis to other Immunoprecise Antibodies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Complementary Tools for Immunoprecise Stock analysis

When running Immunoprecise Antibodies price analysis, check to measure Immunoprecise Antibodies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunoprecise Antibodies is operating at the current time. Most of Immunoprecise Antibodies' value examination focuses on studying past and present price action to predict the probability of Immunoprecise Antibodies' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immunoprecise Antibodies' price. Additionally, you may evaluate how the addition of Immunoprecise Antibodies to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Is Immunoprecise Antibodies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunoprecise Antibodies. If investors know Immunoprecise will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunoprecise Antibodies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
131.6 M
Quarterly Revenue Growth YOY
0.074
Return On Assets
-0.13
Return On Equity
-0.25
The market value of Immunoprecise Antibodies is measured differently than its book value, which is the value of Immunoprecise that is recorded on the company's balance sheet. Investors also form their own opinion of Immunoprecise Antibodies' value that differs from its market value or its book value, called intrinsic value, which is Immunoprecise Antibodies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunoprecise Antibodies' market value can be influenced by many factors that don't directly affect Immunoprecise Antibodies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunoprecise Antibodies' value and its price as these two are different measures arrived at by different means. Investors typically determine Immunoprecise Antibodies value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunoprecise Antibodies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.